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INTRODUCTION
Acute exposure to hyperbaric oxygen (HBO) can result in toxicity to the central nervous system (CNS) (1) . The most onerous manifestation of CNS oxygen toxicity is the onset of generalized tonic-clonic seizures. HBO-induced convulsions are of particular importance to the Navy, as it is a limiting factor in the duration of diving missions involving surface supplied oxygen and use of the LAR V and MK-15/16 closed-circuit SCUBA apparatus, and the application of HBO medical treatment for decompression sickness (2) .
The causal mechanism of HBO-induced seizures is presently unknown. CNS dysfunction as a result of increased exposure to HBO might be related to the deleterious effects of elevated oxygen free radical production (1) . The primary utilization of 02 in the central nervous system occurs during the oxidation of carbohydrates involved in the generation of adenosine triphosphate. Residual 02 in the brain is reduced to reactive oxygen species assumed to be neutralized by endogenous antioxidative compounds (e.g., glutathione system, superoxide dismutase, and catalase). Endogenous defense mechanisms may be overwhelmed in a HBO environment where the production of oxygen free radicals exceeds normal levels (3-6).
The pineal hormone, melatonin (N-acetyl-5-methoxy-tryptamine) is easily taken up in the brain and is considered to be a potent free radical scavenger (4, (7) (8) (9) (10) (11) (12) . Melatonin has also exhibited anticonvulsive properties in various seizure models. The severity of pentylenetetrazolinduced convulsions was reduced in gerbils receiving daily subcutaneous doses of melatonin (13, 14) . Incidence of potassium cyanide-induced convulsions was reduced in mice given subcutaneous melatonin (12) . Kainate-induced convulsions were reduced in rats given intraperitoneal melatonin (15) . The occurrence of iron-induced epileptic EEG discharges was reduced in rats given intraperitoneal melatonin (16) . Dose-dependent anticonvulsive effects of melatonin were observed in convulsions induced by intracerebroventricular administration of quinolinic acid, kainate, glutamate, NMDA, and pentylenetetrazole (17) . However, in most of the aforementioned seizure models, melatonin did not eradicate convulsions. Lapin, et al. (17) reported longer seizure latencies or suppression of seizures as a function of melatonin administration.
Melatonin has not been tested in its capacity as an anticonvulsant in HBO conditions likely to produce seizures (6 atmospheres absolute (ATA)). The goal of this research was to examine melatonin prophylaxis in HBO conditions that reliably produce CNS toxicity.
EXPERIMENT 1
The rationale for using 6 ATA as a dive depth for these experiments was to minimize time to seizure, minimize the onset of pulmonary toxicity as a complicating factor, and to see if extreme dive profiles are affected by interventions.
Melatonin is more prominently known for its involvement in circadian rhythms and sleep (18) . These potential "side-effects" could be equally as harmful in a combat diver scenario, thus we initially sought to test a low dose that might produce prophylaxis in our HBO seizure model. Pablos, et al. (4) , reported a reduction in oxidative stress and elevated production of endogenous antioxidant defenses in brain tissues of rats given 10 mg/kg intraperitoneal melatonin prior to 90 minutes of 4 ATA HBO exposure.
We designed our experiment based upon the assumption that the mean seizure latency in control conditions would be approximately 20 min with a standard deviation of 15 min. We sought to detect a difference between control and treatment conditions when the mean seizure latency of the treatment (i.e., melatonin) was at least 45 min. The rationale for seeking a treatment effect of this size was that it would be operationally important and, assuming depth dependency of any intervention, this time would increase for shallower dives. Our parameters required relatively small sample sizes (n > 7) to produce power estimates > .80 when alpha was set at .05 (19, 20) .
METHODS
Animals and Injectants
Twenty-four, male Sprague-Dawley rats (mean = 330 g, SD = 39.96 g, Charles River) were randomly assigned to one of three experimental conditions; saline (control), 10% dimethylsulfoxide (Sigma D-8779) in saline (DMSO+saline), or 10 mg/kg melatonin (Sigma M-5250) + 10% dimethylsulfoxide-saline (MEL10). Solutions were prepared a few minutes prior to intraperitoneal administration, immediately before HBO exposure.
HBO Exposure
Animals were individually exposed to HBO. The animal was housed in a 28 x 18 x 13 cm Plexiglas cage with air holes and immediately sealed inside a small hyperbaric chamber (approximately 167 liters). After a 90 s flushing period, 100% oxygen was introduced to the chamber at a rate equivalent to 1 foot of sea water (fsw)/s until reaching 165 fsw (6 ATA).
Pressure was maintained at 165±1 fsw for behavioral observation until positive identification of a seizure or pulmonary distress, then the chamber was depressurized at 1 fsw/s and the animal was euthanized.
Behavior Observation
A video camera mounted against a porthole of the hyperbaric chamber provided a clear view of the Plexiglas cage via an external monitor. The primary objective of behavior observation was to identify seizure onset time. The following hallmarks were noted throughout the dive: facial clonus, forelimb clonus, tonic hindlimb extension, generalized tonic-clonic seizure, and running fits. Pulmonary distress (dypsnea, gagging) was identified and used as an ethical guide to terminate HBO exposure. Animals were observed at all times while in the chamber. The seizure duration of> 20 s was selected to ensure positive identification of seizure activity. A list of behavior codes was used as a guide to identify all animal activity during observation (Appendix A). Two dedicated observers verified each other's behavior identification in the animal, and each dive was recorded on videotape for further verification of seizure onset times.
RESULTS
The difference between onset time of a seizure and the time at which the rat (17) . Given that we observed no differences in seizure latency between the control and DMSO+saline conditions in Experiment 1, we only used DMSO+saline as the control in Experiment 2.
METHODS
Animals and Injectants
Thirty, male Sprague-Dawley rats (mean = 350 g, SD = 21.84 g, Charles River) were randomly assigned to one of three experimental conditions; 10% dimethylsulfoxide in saline (DMSO+saline), 75 mg/kg melatonin + 10% dimethylsulfoxide-saline (MEL75), or 150 mg/kg melatonin + 10% dimethylsulfoxide-saline (MEL150). As in Experiment 1, solutions were prepared a few minutes prior to administration and animals were given an intraperitoneal injection immediately before HBO exposure.
HBO Exposure and Behavior Observation
I-IBO exposure and behavior observation were the same as Experiment 1. In this case, however, behavioral data were recorded electronically and later transferred to text for off-line analysis (see Appendix B for example text file).
RESULTS
The difference between seizure onset time and the time at which the animal reached 6 ATA was calculated to measure seizure latency to the nearest minute. Mean seizure latencies were calculated for each treatment; DMSO+saline (37.1, SD = 22.5), MEL75 (33.5, SD = 19.0), and MEL150 (25.5, SD = 11.3). Two animals were surfaced for pulmonary reasons, one in the DMSO+saline group (latency = 84 min), and one in the MEL75 group (latency = 79 min). These animals elevated their respective treatment mean and standard deviation, but had no bearing on the final statistical outcome. There were no significant differences among treatment pairs (MEL75 vs. DMSO+saline, t(18) = -.39,p> .05; MEL150 vs. DMSO+saline, t(18) = -1.46,p > .05; MEL150 vs. MEL75, t (18) .1.14,,p > .05).
CONCLUSIONS
These results suggest that melatonin pretreatment at the dosages used provides no benefit against the occurrence of HBO-induced seizure. We did not observe any effect of intraperitoneal administration of melatonin on HBO-induced seizure latency. Melatonin doses employed here (10, 75 and 150 mg/kg) were comparable to doses producing prophylactic effects in other animal seizure models. Although statistical power was less than anticipated in Experiment 2 given the longer mean seizure latency in the control condition (DMSO+saline) and slightly elevated standard deviations, mean seizure latencies in all of the melatonin conditions were not different from anticipated latencies with no intervention.
Perhaps the severity of this profile (6 ATA HBO) overwhelmed assumed antioxidant defenses of melatonin. Previous research on melatonin's capacity to reduce oxidative stress was conducted under less toxic conditions (4 ATA HBO)(4). It is unclear whether melatonin would limit CNS 02 toxicity in a less severe hyperbaric environment.
RECOMMENDATIONS
1. Application of melatonin to prolong or eradicate the onset of HBO toxicity (seizures) in human diving investigations is not recommended at this time.
2. Further nonhuman animal research on the prophylactic capability of melatonin in an acute HBO environment is not recommended at this time. However, additional studies could be conducted at NMRC with intracerebroventricular administration to elucidate how this method produced the most dramatic anticonvulsant effects of melatonin in other seizure models (17) .
